Abstract
Patients with liver cirrhosis (LC) have decreased gluconeogenic capacity, which leads to decreased availability of sugar and increased availability of fat especially during the fasting period from after the evening meal until morning. Furthermore, due to gluconeogenesis requirements for amino acids being met by the breakdown of muscle protein, skeletal muscle is decreased and the nitrogen balance becomes negative. Thus, patients with LC present with protein energy malnutrition (PEM).Branched chain amino acid (BCAA) therapy for LC is effective for ameliorating this condition by correcting PEM and improving both quality of life (QOL) and prognosis. A late evening snack (LES) using Aminoleban EN for LC has beneficial effects on hepatic parenchymal cells in addition to nutritional effects. A LES using BCAA is both safe and useful, as nutritional and dietary therapy, comprising one part of the four-meal-a-day dietary intervention.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.